专利检索 ap:("Organogenesis, Inc.") AND inv:"WANG, Xianyan" 第 1 页

1.

发明公开
BIOENGINEERED TISSUE CONSTRUCTS AND METHODS FOR PRODUCTION AND USE 审中-公开
标题翻译：生物技术构建的生产和使用的组织建造和方法

公开(公告)号：EP2225361A1

公开(公告)日：2010-09-08

申请号：EP08854614.8

申请日：2008-11-26

申请人： Organogenesis, Inc.

发明人： WANG, Xianyan , FARIA, Katherine, C.

IPC分类号： C12N5/00 , A61L27/60

CPC分类号： C12N5/0068 , A61L27/3633 , A61L27/3683 , A61L27/3804 , C12N5/0698 , C12N2500/25 , C12N2500/36 , C12N2500/38 , C12N2500/40 , C12N2500/50 , C12N2500/90 , C12N2500/92 , C12N2501/11 , C12N2501/148 , C12N2501/395 , C12N2502/094 , C12N2502/1323 , C12N2533/50 , C12N2533/92

摘要： Bioengineered constructs are formed from cultured cells induced to synthesize and secrete endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. The bioengineered constructs of the invention can be treated in various ways such that the cells of the bioengineered constructs can be devitalized and/or removed without compromising the structural integrity of the constructs. Moreover, the bioengineered constructs of the invention can be used in conjunction with biocompatible/bioremodelable solutions that allow for various geometric configurations of the constructs.

2.

发明公开
BIOENGINEERED TISSUE CONSTRUCTS AND METHODS FOR PRODUCING AND USING THEREOF 审中-公开
标题翻译：生物技术制备的生产和使用的组织建造和方法

公开(公告)号：EP2524034A1

公开(公告)日：2012-11-21

申请号：EP11701589.1

申请日：2011-01-14

申请人： Organogenesis, Inc.

发明人： RONFARD, Vincent , BAKSH, Dolores , WANG, Xianyan , WONG, Matthew, Quin-men , CAO, Lan , SAVA, Parid , BOLLENBACH, Thomas , YESILALAN, Esin

IPC分类号： C12N5/0775 , A61L27/36

CPC分类号： C12N5/0663 , A61K2035/124 , A61L27/3633 , A61L27/3804 , A61L27/3834 , A61L27/3886 , A61L27/3891 , C12N5/0667 , C12N5/0668 , C12N2500/25 , C12N2500/38 , C12N2500/90 , C12N2501/02 , C12N2501/11 , C12N2501/115 , C12N2501/148 , C12N2501/39 , C12N2533/90

摘要： Bioengineered constructs are formed from cultured cells induced to synthesize and secrete endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. The bioengineered constructs of the invention can be produced with multiple cell types that can all contribute to producing the extracellular matrix. Additionally or alternatively, one of the multiple cell types can be delivered to a site in the body via the endogenously produced extracellular matrix components to achieve various therapeutic benefits.